311 related articles for article (PubMed ID: 21115797)
1. T-705 (favipiravir) inhibition of arenavirus replication in cell culture.
Mendenhall M; Russell A; Juelich T; Messina EL; Smee DF; Freiberg AN; Holbrook MR; Furuta Y; de la Torre JC; Nunberg JH; Gowen BB
Antimicrob Agents Chemother; 2011 Feb; 55(2):782-7. PubMed ID: 21115797
[TBL] [Abstract][Full Text] [Related]
2. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.
Westover JB; Sefing EJ; Bailey KW; Van Wettere AJ; Jung KH; Dagley A; Wandersee L; Downs B; Smee DF; Furuta Y; Bray M; Gowen BB
Antiviral Res; 2016 Feb; 126():62-8. PubMed ID: 26711718
[TBL] [Abstract][Full Text] [Related]
3. Highly Pathogenic New World Arenavirus Infection Activates the Pattern Recognition Receptor Protein Kinase R without Attenuating Virus Replication in Human Cells.
Huang C; Kolokoltsova OA; Mateer EJ; Koma T; Paessler S
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794024
[TBL] [Abstract][Full Text] [Related]
4. Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.
Huang C; Kolokoltsova OA; Yun NE; Seregin AV; Ronca S; Koma T; Paessler S
J Virol; 2015 Jul; 89(14):7079-88. PubMed ID: 25926656
[TBL] [Abstract][Full Text] [Related]
5. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.
Neuman BW; Bederka LH; Stein DA; Ting JP; Moulton HM; Buchmeier MJ
Antimicrob Agents Chemother; 2011 Oct; 55(10):4631-8. PubMed ID: 21825302
[TBL] [Abstract][Full Text] [Related]
6. Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.
Mateer EJ; Maruyama J; Card GE; Paessler S; Huang C
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051278
[TBL] [Abstract][Full Text] [Related]
7. Potential and action mechanism of favipiravir as an antiviral against Junin virus.
Zadeh VR; Afowowe TO; Abe H; Urata S; Yasuda J
PLoS Pathog; 2022 Jul; 18(7):e1010689. PubMed ID: 35816544
[TBL] [Abstract][Full Text] [Related]
8. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
9. Activity of a phenolic dibenzylsulfide against New World arenavirus infections.
Gowen BB; Jung KH; Sefing EJ; Wong MH; Westover JB; Smee DF
Antivir Chem Chemother; 2014 Jan; 23(4):151-9. PubMed ID: 23337126
[TBL] [Abstract][Full Text] [Related]
10. Development of a new tacaribe arenavirus infection model and its use to explore antiviral activity of a novel aristeromycin analog.
Gowen BB; Wong MH; Larson D; Ye W; Jung KH; Sefing EJ; Skirpstunas R; Smee DF; Morrey JD; Schneller SW
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862280
[TBL] [Abstract][Full Text] [Related]
11. Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.
Radoshitzky SR; Kuhn JH; de Kok-Mercado F; Jahrling PB; Bavari S
Expert Opin Drug Discov; 2012 Jul; 7(7):613-32. PubMed ID: 22607481
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of A771726, the active metabolite of leflunomide, against Junín virus.
Sepúlveda CS; García CC; Damonte EB
J Med Virol; 2018 May; 90(5):819-827. PubMed ID: 29315647
[TBL] [Abstract][Full Text] [Related]
13. Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models.
Kim JA; Seong RK; Kumar M; Shin OS
Viruses; 2018 Feb; 10(2):. PubMed ID: 29425176
[TBL] [Abstract][Full Text] [Related]
14. Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever.
Mendenhall M; Russell A; Smee DF; Hall JO; Skirpstunas R; Furuta Y; Gowen BB
PLoS Negl Trop Dis; 2011 Oct; 5(10):e1342. PubMed ID: 22022624
[TBL] [Abstract][Full Text] [Related]
15. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses.
Radoshitzky SR; Abraham J; Spiropoulou CF; Kuhn JH; Nguyen D; Li W; Nagel J; Schmidt PJ; Nunberg JH; Andrews NC; Farzan M; Choe H
Nature; 2007 Mar; 446(7131):92-6. PubMed ID: 17287727
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of arenavirus infection by a novel fusion inhibitor.
Gowen BB; Naik S; Westover JB; Brown ER; Gantla VR; Fetsko A; Dagley AL; Blotter DJ; Anderson N; McCormack K; Henkel G
Antiviral Res; 2021 Sep; 193():105125. PubMed ID: 34197863
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.
Ortiz-Riaño E; Ngo N; Devito S; Eggink D; Munger J; Shaw ML; de la Torre JC; Martínez-Sobrido L
J Virol; 2014 Jan; 88(2):878-89. PubMed ID: 24198417
[TBL] [Abstract][Full Text] [Related]
18. Favipiravir (T-705), a novel viral RNA polymerase inhibitor.
Furuta Y; Gowen BB; Takahashi K; Shiraki K; Smee DF; Barnard DL
Antiviral Res; 2013 Nov; 100(2):446-54. PubMed ID: 24084488
[TBL] [Abstract][Full Text] [Related]
19. A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans.
Botten J; Whitton JL; Barrowman P; Sidney J; Whitmire JK; Alexander J; Kotturi MF; Sette A; Buchmeier MJ
J Virol; 2010 Oct; 84(19):9947-56. PubMed ID: 20668086
[TBL] [Abstract][Full Text] [Related]
20. Guinea Pig Transferrin Receptor 1 Mediates Cellular Entry of Junín Virus and Other Pathogenic New World Arenaviruses.
Hickerson BT; Westover JB; Wang Z; Lee YM; Gowen BB
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
